Скачать или смотреть The Scientist Symposium: The Future of CRISPR

[Abstract]
Idea to IND: Powering Tomorrow’s Therapies with CRISPR for Clinical Impact

CRISPR-based gene editing has emerged as a transformative technology in the development of next-generation therapeutics. GenScript’s comprehensive portfolio supports a wide range of CRISPR modalities—including Cas9, Cas12a, base editing, and prime editing—empowering researchers and developers to advance genome editing from discovery through IND submission and clinical trials.

As a global leader in life science services, GenScript delivers scalable, regulatory-ready solutions with cGMP-compliant manufacturing, rigorous quality control, and fast turnaround times. Built on a foundation of technical excellence and regulatory expertise, we enable efficient, reliable, and compliant workflows to accelerate CRISPR-based therapeutic innovation.
Whether you're in early-stage research or preparing for clinical trials, attend this webinar to discover how end-to-end development solutions can de-risk and accelerate your therapeutic pipeline.

[Speaker]
Dr. Daksha Patel is the Senior Segment Marketing Manager for Cell Therapy at GenScript USA Inc., where she focuses on delivering comprehensive solutions to support cell and gene therapy development. She leads strategic marketing initiatives and market research efforts tailored to the evolving needs of this dynamic field. Dr. Patel brings a strong scientific foundation and deep industry experience to her role. Before transitioning into marketing, she served as a Senior Scientist and Technical Product Manager at GenScript, contributing to the development and commercialization of innovative Cell & Gene therapy products. With over a decade of experience across academic and industry settings, she offers a well-rounded perspective that bridges science and strategy.

Learn more here: https://www.genscript.com/one-stop-so...
Explore the symposium: https://www.the-scientist.com/the-fut...